COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study.
Sci Rep
; 12(1): 12269, 2022 07 18.
Article
in En
| MEDLINE
| ID: mdl-35851303
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Sci Rep
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido